226 related articles for article (PubMed ID: 11396172)
1. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
Lin J; Page C; Jin X; Sethi AO; Patel R; Nunez G
Anticancer Res; 2001; 21(2A):831-9. PubMed ID: 11396172
[TBL] [Abstract][Full Text] [Related]
2. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
4. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
6. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
Oncogene; 1999 Oct; 18(41):5703-13. PubMed ID: 10523849
[TBL] [Abstract][Full Text] [Related]
7. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
[TBL] [Abstract][Full Text] [Related]
8. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
10. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53.
Jin X; Burke W; Rothman K; Lin J
Anticancer Res; 2002; 22(2A):659-64. PubMed ID: 12014634
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines.
Ng AY; Bales W; Veltri RW
Anal Quant Cytol Histol; 2000 Feb; 22(1):45-54. PubMed ID: 10696460
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in prostate cancer: progressive and therapeutic implications (Review).
Wang G; Reed E; Li QQ
Int J Mol Med; 2004 Jul; 14(1):23-34. PubMed ID: 15202013
[TBL] [Abstract][Full Text] [Related]
13. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2-related protein family gene expression during oligodendroglial differentiation.
Itoh T; Itoh A; Pleasure D
J Neurochem; 2003 Jun; 85(6):1500-12. PubMed ID: 12787069
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human proapoptotic molecules in yeast S. cerevisiae.
Guscetti F; Nath N; Denko N
FASEB J; 2005 Mar; 19(3):464-6. PubMed ID: 15632273
[TBL] [Abstract][Full Text] [Related]
18. Bcl-XL protects cancer cells from p53-mediated apoptosis.
Schott AF; Apel IJ; Nuñez G; Clarke MF
Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
Li X; Marani M; Mannucci R; Kinsey B; Andriani F; Nicoletti I; Denner L; Marcelli M
Cancer Res; 2001 Feb; 61(4):1699-706. PubMed ID: 11245486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
